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Abstract Variouscellsincludingpolymorphonuclearleukocytes, alveolarmacrophages andtype-IIpneumocytesmay
be a source of exhaledhydrogenperoxide (H2O2) in airways of humans.H2O2 canconvert intohydroxylradicals leading
to peroxidative damage of airways structures and formation of volatile thiobarbituric acid-reactive substances (TBARs).
We testedwhether exhalation of H2O2 and TBARs byhealthy subjects depends on reactive oxygen species generation
from blood phagocytes. The expired breath condensate (EBC) and blood specimens were collected from 41 healthy,
never smoked subjects (mean age 20.770.8 years,18 men, 23 women) and then the EBC concentration of H2O2 and
TBARs and 2105 M fMLP-provokedwhole blood chemiluminescence responsewasmeasured.Themeanconcentra-
tionofH2O2 and TBARsin EBCwas 0.2870.17 and 0.0470.13 mMwithratio ofpositivereadingsreaching 36/41and 4/41,
respectively.The chemiluminescence response to n-formyl-methionyl-leveyl-phenylalanine stimulationwas obtained in
all cases and the following parameterswere estimated : basal chemiluminescence (bCl) ;peakchemiluminescence (pCl);
absolute light emission (aCl); and peaktime.H2O2 levels in EBCpositively correlated (Spearmann test) with bCl (r=0.41,
Po0.01), pCl (r=0.47, Po0.01), aCl (r=0.49, Po0.001), peaktime (r=0.52, Po0.001) in the whole group and with bCl
(r=0.56, Po0.01), pCl (r=0.67, Po0.01), aCl (r=0.66, Po0.01) inmen andwith aCl (r=0.41, Po0.05) and peaktime (r=0.48,
Po0.05) in women.No association between exhaled TBARs and blood phagocytes activity was found.These results
indicate that H2O2 exhalation in healthy never smoked subjects depends on ability of blood phagocytes to generate
reactive oxygen species.r2003 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2003.1506, available online athttp://www.sciencedirect.com
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Human respiratory tract contains variety of cells that
are able to release reactive oxygen species (ROS) such
as superoxide radicals and hydrogen peroxide (H2O2).
These include polymorphonuclear leukocytes (PMNs),
alveolar macrophages, mastocytes and type-II pneumo-
cytes (1^3). H2O2 in the presence of iron or copper ions
can convert into hydroxyl radicals (4) and induce perox-
idative damage to various biomolecules leading to gen-
eration of volatile thiobarbituric acid reactive
substances (TBARs) (5,6). Part of H2O2 not decomposedReceived19 February 2002, accepted in revised form11October 2002
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mediated processes can evaporate from the surface of
epithelial lining £uid being exhaled with expiratory air.
Healthy subjects exhale detectable levels of H2O2 and
occasionally TBARs that are rised by cigarette smoking
and chronic in£ammatory processes in the airways (7^
12). Thus exhaled H2O2 and also TBARs may serve as
one of non-invasive markers of airways in£ammation
and oxidative stress. There is indirect evidence that
H2O2 exhalation is associated with the number and ac-
tivity of phagocytes in airways of patients with lung in-
£ammatory disorders. In asthmatics the concentration
of H2O2 in expired breathe condensate (EBC) positively
correlated with intracellular calcium rise in stimulated
PMNs (13) and the number of eosinophils in induced spu-
tum (14). Also, H2O2 levels in EBC of patients with adult
respiratorydistress syndrome correlatedwith plasma ly-
sozyme that re£ects in vivo neutrophil turnover (15). In
TABLE 1. Characteristic of study subjects.
Whole group Men Women
n 41 18 23
Age 20.770.8 20.670.8 20.870.8
BMI 21.772.3 23.372.3 20.571.6
FEV1% 96.674.2 101.776.7 90.973.8
FEV1/FVC % 94.873.9 91.374.2 95.874.1
FVC % 104.874.3 109.874.1 100.974.6
Erythrocytes106/ml 4.470.7 4.770.9 4.170.7
Hemoglobin g/dl 13.971 14.973.4 13.072.5
WBC103/ml 6.272.1 6.071.7 6.272.1
PMNs103/ml 4.371.5 4.171.4 4.771.6
Monocytes103/ml 0.370.1 0.470.1 0.370.2
BMIFbody mass index, FVCFforced vital capacity,
FEV1Fforced expiratory volume in the ¢rst second,
WBCFwhite blood cells, PMNsFpolymorphonuclear
leukocytes, TBARsFthiobarbituric acid reactive sub-
stances.FEV1,FVC,FEV1/FVC are expressed as percent of
predicted value.The predicted valueswere derived from
the European Community for Steel and Coal statement
(40).
EXHALEDH2O2 ANDBLOODCHEMILUMINESCENCE 719addition, inhaled steroids that suppress in£am-
matory cells activity decreased H2O2 exhalation in
children and adult patientswith asthma (16,17). However,
no studies devoted to direct association between
phagocytes ability to produce ROS and exhalation of
H2O2 and TBARs by healthy subjects have been
published so far.
The number and activity of phagocytes in respira-
tory tract of patients with chronic airways in£ammation
(e.g. bronchial asthma, chronic obstructive pulmonary
disease) is higher than that found in healthy subjects
(18,19). This suggests that contribution of other H2O2
sources like alveolar epithelial cells to total pool of
exhaled H2O2 may be higher in healthy subjects than
in these patients. On the other hand, type-II pneumo-
cytes and phagocytes use probably the same NADPH
oxidase-dependent pathways for ROS generation
(2,3,20).Therefore, the purpose of this study was to in-
vestigate whether H2O2 and TBARs exhalation by
healthy subjects depends on ability of blood phagocytes
to generateROS after stimulationwith chemotacticpep-
tide n-formyl-methionyl-leucyl-phenylalanine (fMLP) in a
whole blood chemiluminescence assay. We found that
concentration of H2O2 in EBC collected from healthy
never smoked subjects positively correlated with the in-
tensity of blood phagocytes chemiluminescence re-
sponse to fMLP.
MATERIALANDMETHODS
Reagents
Dimethyl sulfoxide (DMSO) and thiobarbituric acid
(TBA), peroxidase from horseradish type-II (HRP),
homovanillic acid, fMLP, luminol and butylated hydroxy-
toluenewerepurchased fromSigma (St.Louis,MO,USA).
Sterile Ringer solution (pH 7.4)was fromBiomed (Lublin,
Poland). All other reagents were obtained from POCH
(Gliwice, Poland) andwere of analytical grade. fMLP was
dissolved in DMSO to a ¢nal concentration 2102M
and stored at801Cuntil assay.This solutionwas diluted
with sterile 0.9%NaCl to fMLP concentration 4104M
just before the use. Aqueous solution of HRP (10U/ml1)
and homovanillic acid (4mM) were prepared freshly be-
fore the assay. Luminol solution was prepared by dissol-
ving 25mg luminol in 90ml 0.1MNa2HPO4 and then pH
was adjusted to 7.4 with1NHCl and volume ¢lled up to
100ml with distilled water (21). Afterwards the solution
was ¢ltered through 0.2mMMillipore ¢lter and stored at
41C in the dark for not longer than 2 weeks.TBA solu-
tionwas preparedbydissolving 0.67 gTBA in100ml deio-
nized water and then diluted 1:1with glacial acetic acid.
Sterile, deionized water (resistance418MOcm, HPLC
Water Puri¢cation SystemUSF ELGA,England)wasused
throughout the study.Study population
Forty-one never smokedhealthy volunteers (18men and
23 women), students of the second year of Medical Fa-
culty of Medical University were included in the study
(Table1).They were free of any medication, had not suf-
fered from any infectious diseases for 3months prior the
study and routine physical examination showed nothing
abnormal. No women was pregnant nor used oral con-
traceptives.
Study design
Subjects were asked to attend the laboratory between
811 and 1011 for EBC collection. Then the spirometry
was performed with Lungtest 1000 spirometer (MES
S.c.,Krako¤ w,Poland) equippedwith softwarecompatible
to American Thoracic Society standards (22) and 10ml
aliquots of blood were drawn into EDTA K3 Vacuette
andZSerumClot ActivatorVacuette tubes (Greiner La-
bor technik) for evaluation of resting and fMLP-induced
whole blood chemiluminescence and determination of
serumTBARs levels. All healthy volunteers involved in
the study were given informed consent and the study
protocol was approved by Ethics Committee of Medical
University of Lodz.
Collection of expired breath condensate
The collecting device consistedof amouthpiecewith sal-
iva trap connected to a glass Liebig tubecooler (cooling
720 RESPIRATORYMEDICINEand collecting tube 55 cm length, internal diameter
10mm, the external jacket diameter 36mm) (Labmed,
Lodz, Poland cat no 6010). The tube was cooled
with ethanol pumped in the closed circuit and its
temperaturewas kept at91CwithMulti Temp III (Phar-
macia Biotech). This temperature was the lowest one
that allowed to collect liquid EBC in the sterile plastic
tube covered with ice (Sarstedt, Numbrecht, volume
13ml, internal diameter 14mm) mounted at the base
of Liebig tubecooler. Preliminary experiments showed
that further decrease in ethanol temperature caused
congelation of EBC inside the cooling tube and stopped
its collection.The EBCwas always collectedbetween 811
and1011.Volunteerswere asked to breathe out through a
mouthpiece and to breathe in with the mouthpiece
removed, for 20min. Each subject wore a nose clip and
rinsed their mouth with distilled water just before
and at 7 and 14min of collection (7,8). At the end of
collection, 5^6ml aliquots of EBC were transferred
to Eppendorf tubes and stored at 801C for not more
than 7 days until H2O2 and TBARs measurement (8).
The respiratory rate during EBC collection ranged
from17 to 23 breaths/min. Previous studies showed that
5-fold rise in respiratory frequency and minute ventila-
tion did not change signi¢cantly the concentration of
H2O2 in EBC (23). In addition, hyperventilation related
to moderate exercise did not change signi¢cantly the
H2O2 and TBARs exhalation in healthy subjects (7). Six
subjects (four men, two women) were asked to attend
two EBC collection sessions in 30min intervals. The re-
producibility for determined EBC H2O2 concentrations
was11.6%.
Measurement of H2O2 in expiredbreath
condensate
The concentration of H2O2 in EBC was measured ac-
cording to themethodof Ruch etal. (24)with somemod-
i¢cations (8) Brie£y, 600ml of EBCwasmixedwith 600ml
of HRP solution (1U/ml) containing 100mM homovanillic
acid and was incubated for 60min at 371C. Then, the
samplewasmixedwith150ml 0.1Mglycine ^NaOHbu¡er
(pH12.0) with addition of 25mM EDTA and emission at
420nm after specimen excitation at 312nm was mea-
sured using a Perkin Elmer Luminescence Spectrometer
LS-50B (Norwalk, CT, USA). Readings were converted
into mM using the regression equation Y=0.012
(XX0)0.007 (whereY=micromoles of H2O2 per litre
of expired breath condensate; X=intensity of emission
at 420nm expressed in arbitrary units; X0=intensity of
emission given by reference sample receiving deionized
water instead of EBC) (8).The lower limitofH2O2 detec-
tion was 0.083mM (6).The intra-assay variability did not
exceeded 2% for standard H2O2 solutions ranging from
0.1to 0.5mM.Measurement of TBARs in expiredbreath
condensate
The content of TBARs in EBC was determined as pre-
viously described (8). Brie£y, 100ml of the condensate
was mixed with 2ml of TBA solution, boiled for 30min,
allowed to cool in ambient temperature and then chro-
mogen was extracted into 2.5ml of butanol by vigorous
shaking for 1min. Following centrifugation (10min,
1500 g, 251C), TBARs were measured spectro£uori-
metrically, excitation at 515nm, emission at 546nm (25).
Readings were converted into mM using the regression
equation Y=0.39 (XX0)-1.32 (where Y=micromoles of
TBARs per liter of EBC; X=intensity of emission at 546
nm expressed in arbitrary units; X0=intensity of emis-
sion given by reference sample receiving deionizedwater
instead of EBC).Tetramethoxypropane (0.01^50mM)was
used as an external standard and the method sensitivity
was 0.05mM (8). The intra-assay variability did not ex-
ceeded 3% for 0.1and 0.5mMtetramethoxypropane solu-
tion.
Measurement of TBARs in serum
SerumTBARs levels were determined as previously de-
scribed (26). Brie£y, 0.5ml of 0.05M H2SO4 and 0.25ml
of 1.23M trichloroacetic acid were added to 0.05ml of
serum, mixed and then centrifuged for 10min (1500g,
41C). The supernatant was discarded and mixed with
2mlof distilledwater, 0.01ml of 4.53nMbutylated hydro-
xytoluene in methanol and 0.5ml of TBA solution. The
obtained mixture was incubated for 30min in a water
bath at 1001C in tightly closed tubes. After cooling,
2.5mlof butanolwas added to the tubes, and after inten-
sive shaking centrifuged for 10min (1500g, 201C). Mea-
surements were made in the supernatant of butanol
layer.Fluorescencewasmeasured at an excitation wave-
length of 515nm and an emission wavelength of 546nm.
Readings were converted into mM using the calibration
curve obtained for tetramethoxypropane (0.01^50mM).
The control containeddeionizedwater instead of serum.
Whole blood chemiluminescence assay
The resting and fMLP-induced whole blood chemilumi-
nescence (Cl) was measured according to the method
of Kukovetz et al. (21) Venous blood was drawn into
sterile vacuette with EDTA just after EBC collection.
Then 3ml blood specimenwas added to 947ml ofmixture
solution placed in the 1251 luminometer (Bio-Orbits,
Turku,Finland) and incubated for 30min at 371C. After-
wards the resting luminescence was recorded continu-
ously for 1min and then 50ml fMLP solution was added
by an automatic dispenser to ¢nal concentration of
2105M and measurement was continued for the
further 7min.The followingparameterswere calculated:
TABLE 2. H2O2 and TBARs concentrations in expired
breath condensate of healthy subjects.
Subjects H2O2 (mM) TBARs (mM)
Whole roup 0.2870.17 0.0470.13
Men 0.3370.19 0.0770.18
Women 0.2470.14 0.0170.04
Specimens of expired breath condensate were col-
lected between 811 and1011 and H2O2 and TBARs con-
centrations were determined £uorimetrically with
homovanillic andthiobarbituric acidmethod,respectively.
EXHALEDH2O2 ANDBLOODCHEMILUMINESCENCE 721basal chemiluminescence (bCl), peak chemiluminescence
(pClFmaximal Cl signal reached after fMLP addition),
absolute light emission from 3ml of tested whole blood
specimen after addition of fMLP (aClFarea under the
CL intensity curve after fMLP addition till returning to
baseline) and peaktime (time from fMLP addition to ap-
pearance of maximal Cl signal) (Fig.1). In all cases the Cl
signal returned to baseline between 6th and 8th min of
recording. Individual results were obtained from tripli-
cate experiments and bCl and pClwere expressed in ar-
bitrary units (aU), while aCl was expressed in
aU seconds (aU s). The intra-assay variation was
3.7% , 2.3 % ,9.8% and 4.7% (n=6) for bCl , aCl, peaktime
and pCl , respectively. The mixture solution was pre-
pared freshly before the assay by adding1ml Ringer solu-
tion, 5ml 1.41mM luminol solution, 0.2ml 277.5mM
glucose solution to 3.6ml distilled water (21). Blood cell
count was performed with ABX MICROS analyser
(AVL,Montpellier France).
Statistical analysis
Data are expressed as mean7SD. For readings that gave
results below the method sensitivity the H2O2 and
TBARs concentration in EBCwas assumed 0nM.The dif-
ferences between groups were computed with Mann^
Whitney U-test or Friedman ANOVA test according to
the sample distribution.The di¡erences between appro-
priate ratios of positive H2O2 and TBARs readings were
determined with chi-square test. Correlation coe⁄-
cientswere calculatedby the Spearmann test. In all cases
a P value ofo0.05 was considered signi¢cant.
RESULTS
The concentration ofH2O2 and TBARs in EBC of healthy
never smoked subjects was 0.2870.17mM and0
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FIG. 1. Typical curve of whole blood chemiluminescence assay.Th
and placed in luminometer.Baseline Clwas recorded over1min an
bClFbasalchemiluminescence; pClFpeakchemiluminescence (m
sion after additionof fMLP (areaunder the CLintensitycurve after f
addition to pCl appearance. All parameters except of peaktime an
expressed in seconds and arbitraryunits seconds.0.0470.13mM. There were no di¡erences in exhalation
of these compounds between men and women
(Table 2).The ratio of positive H2O2 readings (above the
method sensitivity) in the whole groupwas much higher
than that forTBARs (36/41vs. 4/41,P=0.0001). In opposite
to EBC specimens the majority of serum samples
was positive forTBARs (4/41vs. 28/41, P=0.001) and their
mean concentrations reached 0.9371.25mM for the
whole group, 1.0471.60mM for men and 0.8470.93mM
for women. The generation of ROS by circulating
phagocytes (PMNs and monocytes) was evaluated by
means of the whole blood chemiluminescence assay.
Phagocytes were stimulated by fMLP addition and in all
cases the Cl response was obtained. Four parameters
of Cl response were measured and no signi¢cant e¡ect
of sex on ROS generation in the whole blood assay was
noted (Table 3). Both, pCl and aCl correlatedwithWBC
count (r=0.38, 0.34, Po0.05) and blood phagocytes
(PMNs and monocytes) count (r=0.33, 031, Po0.05).
Similar correlation coe⁄cients may result from strong
correlation betweenWBC count and blood phagocytes
count (r=0.95,Po0.0001). Analysis of correlations of EBCe [s]
300 480420360
reemicro liters of bloodweremixedwith 947 ml ofmixture bu¡er
d then fMLP to ¢nal concentration 2105 M was added (arrow).
aximal Clsignalreachedafter fMLPaddition); aClFtotallightemis-
MLPadditiontillreturning tobaseline); peaktimeFtime fromfMLP
d aCl were expressed in arbitrary units. Peaktime and aCl were
TABLE 3. Parameters of fMLP-induced whole blood
chemiluminescence response inhealthy subjects.
Clparameter Whole group Men Women
bCl aU 1.070.3 1.070.2 1.070.3
pCl aU 1.771.1 1.971.6 1.570.6
aCl aUs 559.17271.3 607.47365.5 516.57153.2
Peaktime s 198756 224745 172766
ClFchemiluminescence; bClFbasal chemilumines-
cence; pClFpeak chemiluminescence after fMLP addi-
tion; aClFabsolute light emission from 3 ml of assayed
whole blood specimen after addition of fMLP; peakti-
meFtime from fMLP addition to pCl appearance; aU-
Farbitrary units; No signi¢cant di¡erences between
men andwomenwere found.
TABLE 4. Correlations (r) between exhaled H2O2 and
parameters of whole blood chemiluminescence response
inhealthy subjects.
Clparameters H2O2 levelin expired breath condensate
Whole group Men Women
bCl 0.41** 0.56** 0.36
pCl 0.47** 0.67** 0.35
aCl 0.49*** 0.66* 0.41*
peaktime 0.52*** 0.37 0.48*
ClFchemiluminescence; bClFbasal chemilumines-
cence; pClFpeak chemiluminescence after fMLP addi-
tion; aClFabsolute light emission from 3 ml of whole
blood after additionof fMLP; peaktimeFtime from fMLP
additionto pCl appearance.
*Po0.05.
**Po0.01.
***Po0.001.
722 RESPIRATORYMEDICINEH2O2 levels with parameters of fMLP-induced Cl re-
sponse showed many statistically signi¢cant results (Ta-
ble 4). Exhaled H2O2 positively correlated with bCl
(Fig. 2), pCl, aCl (Fig 3) and peaktime in thewhole group
of healthy volunteers. There was no signi¢cant corre-
lation between EBC H2O2 concentrations and
WBC (r=0.05, P=0.75) and blood phagocytes count
(r=0.06, P=0.70). In man subgroup the levels of H2O2
correlated with bCl, pCl, aCl while in the women the
signi¢cant association between exhaled H2O2 and
aCl, and peaktime was found (Table 4). No signi¢cant
correlationswere observedbetween exhaled and serum
TBARs and WBC count , blood phagocytes count and
parameters of fMLP-induced Cl response (data not
shown).
DISCUSSION
We found that exhalation of H2O2 by healthy never
smoked subjects correlateswith the ability of blood pha-
gocytes to produce ROS as determined by the whole
blood chemiluminescence assay.The positive correlation
of EBCH2O2 levelswith restingproduction of ROS (bCl)
as well as with parameters describing the fMLP-induced
ROS generation (pCl, aCl , peaktime) was found. The
mean number of monocytes was 14-fold lower than
number of PMNs in assayed blood specimens (Table 1).
Therefore,PMNs seem themain source of ROS including
H2O2 in the whole blood chemiluminescence assay. It
suggests that exhaled H2O2 mainly derives from PMNs
thatmigrate fromcirculation into airways of healthy sub-
jects.This conclusion is surprising in the light of airways
anatomical conditions where PMNs compose theminor-
ity of phagocytes capable to produce and release H2O2.
Normally, alveolar macrophages contribute to 80^90%
whilst PMNs to1^4% of bronchoalveloar lavage £uid to-
tal cell count, respectively (27). Alveolar type-II cells
are also able to generate H2O2 (2,3). Although, in vitrotype-II cells produce 4.4 times lessH2O2 thanphagocytes
(3) their high number representing about15%of the total
cell lung population (28) make them important potential
source ofH2O2 in the airways.On the other hand, alveo-
lar macrophages release catalase that is recognized as
the main antioxidant macromolecule of epithelial lining
£uid (29). Similarly, alveolar type-II cells decompose
H2O2 by catalase-dependent mechanisms (30,31) and
their intracellular catalase load is 4.5 -fold higher than
that of alveolar macrophages (3). Thus catalase activity
derived fromboth alveolarmacrophages and type-II cells
maydiminish their netcontribution as sources of exhaled
H2O2 in healthy subjects.This is consistent with the ob-
servation that PMNs but not alveolar macrophages are
responsible for the rise in ROS production in airways of
healthy volunteers after exposition to ozone (32).These
may explain the positive correlation of H2O2 levels in
EBC with activity of blood PMNs although these cells
are not so numerous as alveolar macrophages or type-II
pneumocytes in airways of healthy subjects. It should be
noted that PMNsprimarygranules also contain catalase,
(33) however, its contribution to antioxidant screen of
epithelial lining £uid seems low (29).
Human plasma contains detectable amounts of H2O2
(4). It cannotbe excluded that H2O2 released from circu-
latory phagocytes may di¡use from blood streem
through pulmonary endothelium into lower airways and
evaporate from epithelial lining £uid.
This hypothesismayclearly explain the associationbe-
tween EBCH2O2 levels and activityof bloodphagocytes.
However, plasma contains varietyof compounds that de-
compose H2O2 (4). In addition, erythrocytes are also
able to rapidly scavenge H2O2 (34) and endothelium of
pulmonary vessels and airways epithelium contains anti-
oxidants that may suppress the H2O2 £ow from blood
into lungs in healthy subjects. The dependency of EBC
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FIG. 3. Positive correlation between H2O2 concentrations in expired breath condensate of healthynever smoked subjects and ab-
solute lightemission (aCl) from 3 ml of assayedwhole blood specimen after addition of fMLP.
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FIG. 2. Positive correlation between H2O2 levels in expired breath condensate of healthynever smoked subjects and basal chemi-
luminescence (bCl) of whole blood.
EXHALEDH2O2 ANDBLOODCHEMILUMINESCENCE 723H2O2 levels on expiratory £owrate (35) suggests impor-
tant airways contribution to exhaled H2O2 . Since air-
ways epithelial cells did not produce large amounts of
ROS the di¡usion of H2O2 fromblood into airways could
be one of possible explanation. On the otherhand, the
EBC collection at higher expiratory £ow rate resulted
in the decrease in H2O2 levels (35). Under these condi-
tions more droplets of airways respiratory £uid are col-
lected in cooled condenser (36). This argues against
hypothesis that airways are more important source of
exhaled H2O2 than alveoli.
Alveolarmacrophages and PMNs generate superoxide
radical and H2O2 via the protein kinase C-activated
NADPH oxidase (37). Recent studies showed that type-
II pneumocytes use the plasma membrane boundNADPH oxidase-like system for ROS production. Its ac-
tivation was induced by variety of agonists (arachidonic
acid, zymosan, bacteria) known as factors evoking
H2O2 response in phagocytes and was blocked by pro-
tein kinase C inhibitors (20).These suggest thatmajority
ofH2O2 evaporating fromlower airways surface is a pro-
duct of NADPH oxidase activity independently of its cell
origin. It is possible that regulation of NADPH oxidase
activity is similar in phagocytes and type-II cells (20,37).
Thus blood PMNs ability to produce ROS may re£ect
H2O2 release from cells localized in the close neighbor-
hood of lower airways epithelial lining £uid.This may be
another explanation of positive association between ex-
haled H2O2 and ROSproduction in thewhole blood sys-
tem. Other sources like mitochondria of lung cells,
724 RESPIRATORYMEDICINEarachidonic acid metabolism, xanthine oxidase activity
may also contribute to exhaledH2O2 (4,1).However, they
probably have importance in subjects with lung in£am-
matory processes or those exposed to hyperoxia (1).
No association was found between ROS production
by blood phagocytes and exhaled and serum TBARs.
Thesemayresult fromhighratio of negativeTBARs read-
ings in EBC and from su⁄cient serum antioxidant de-
fence to neutralize ROS derived from phagocytes.
Perhaps, in healthy subjects without any in£ammatory
processes the baseline ROS production by circulating
phagocytes is too low to induce peroxidative damage to
plasma biolmolecules with subsequent TBARs genera-
tion.Negative EBC TBARs readings in subjects with de-
tectable serumTBARs indicate that these end products
of lipid peroxidation did not di¡use from blood into air-
ways epithelial lining £uid.
We did not observe any signi¢cant e¡ect of sex on
resting and fMLP-provoked light emission in the whole
blood chemiluminescence assay. This is consistent with
results of previous studies showing no di¡erences be-
tween men and women in respect of ROS production in
the whole blood system (21,38).We also did not ¢nd sig-
ni¢cantdi¡erences inH2O2 EBC levels betweenmen and
women. This di¡ers from results of our previous study
showing higher H2O2 exhalation in women (7).Our pre-
sent study involved almost 2 times younger subjects and
thismay be a causation of di¡erent results.
In conclusion we found that H2O2 exhalation by
healthy subjects depends on ability of blood phagocytes
to produceROS.This clearly showsphagocytes as impor-
tant source of exhaled H2O2. This ¢nding may also be
helpful for understanding the phenomenon of increased
H2O2 exhalation in patients without pulmonary pathol-
ogy but with systemic processes that enhance activity of
circulating phagocytes, e.g. subjectswith severebrain in-
jury without pulmonary in¢ltrates (23) or those with
polytrauma not involving the chest (39).
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